CSIMarket
 
Avadel Pharmaceuticals Plc  (NASDAQ: AVDL)
 

Avadel Pharmaceuticals Plc's Suppliers Performance

AVDL's Supply Chain




 
AVDL Costs vs Sales of Suppliers Growth Avadel Pharmaceuticals Plc's cost of sales deteriorated by -33.13 % year on year, relative to one quarter ago cost of sales fell by -35.34 % in Q3.

• More on AVDL Suppliers



Avadel Pharmaceuticals Plc's cost of sales deteriorated by -33.13 % year on year, compare to one quarter ago cost of sales fell by -35.34 % in Q3.

• More on AVDL Suppliers




Avadel Pharmaceuticals Plc's Comment on Supply Chain









AVDL's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Avadel Pharmaceuticals Plc 2,189.59 248.76 -0.28 154
SUBTOTAL 0.00 0.00 0.00 -


Sources: Avadel Pharmaceuticals Plc's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Avadel Pharmaceuticals Plc’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.